Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Cipla
Accenture
Mallinckrodt
Citi
Farmers Insurance
Deloitte
Express Scripts

Generated: August 15, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077220

« Back to Dashboard

NDA 077220 describes PILOCARPINE HYDROCHLORIDE, which is a drug marketed by Akorn Inc, Impax Labs, Innogenix, Lannett Co Inc, and Perrigo Pharma Intl, and is included in five NDAs. It is available from six suppliers. Additional details are available on the PILOCARPINE HYDROCHLORIDE profile page.

The generic ingredient in PILOCARPINE HYDROCHLORIDE is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
Summary for 077220
Tradename:PILOCARPINE HYDROCHLORIDE
Applicant:Lannett Co Inc
Ingredient:pilocarpine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 077220
Suppliers and Packaging for NDA: 077220
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 077220 ANDA KAISER FOUNDATION HOSPITALS 0179-0153 N 0179-0153-70
PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 077220 ANDA Lannett Company, Inc. 0527-1313 N 0527-1313-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Oct 14, 2005TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength7.5MG
Approval Date:May 6, 2009TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Healthtrust
AstraZeneca
Julphar
Harvard Business School
Citi
Dow
QuintilesIMS
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.